False-negative nasopharyngeal severe acute respiratory coronavirus virus 2 (SARS-CoV-2) reverse-transcription polymerase chain reaction (RT-PCR) in immunocompromised patients resulting in healthcare worker exposures

被引:1
作者
Beam, Elena [1 ,2 ]
Meyer, Michelle L. [2 ]
O' Horo, John C. [1 ,2 ,3 ]
Breeher, Laura E. [4 ,5 ]
机构
[1] Mayo Clin, Div Infect Dis, Rochester, MN 55905 USA
[2] Mayo Clin, Infect Prevent & Control, Rochester, MN 55905 USA
[3] Mayo Clin, Div Pulm & Crit Care Med, Rochester, MN USA
[4] Div Prevent Occupat & Aerosp Med, Rochester, MN USA
[5] Occupat Hlth Serv, Rochester, MN USA
关键词
COVID-19; VACCINE;
D O I
10.1017/ice.2021.447
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:1971 / 1972
页数:2
相关论文
共 6 条
[1]   Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients [J].
Boyarsky, Brian J. ;
Chiang, Teresa P. -Y. ;
Ou, Michael T. ;
Werbel, William A. ;
Massie, Allan B. ;
Segev, Dorry L. ;
Garonzik-Wang, Jacqueline M. .
TRANSPLANTATION, 2021, 105 (08) :E82-E83
[2]   Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients [J].
Boyarsky, Brian J. ;
Werbel, William A. ;
Avery, Robin K. ;
Tobian, Aaron A. R. ;
Massie, Allan B. ;
Segev, Dorry L. ;
Garonzik-Wang, Jacqueline M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (21) :2204-2206
[3]   Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases [J].
Boyarsky, Brian J. ;
Ruddy, Jake A. ;
Connolly, Caoilfhionn M. ;
Ou, Michael T. ;
Werbel, William A. ;
Garonzik-Wang, Jacqueline M. ;
Segev, Dorry L. ;
Paik, Julie J. .
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (08) :1098-1099
[4]   Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia [J].
Herishanu, Yair ;
Avivi, Irit ;
Aharon, Anat ;
Shefer, Gabi ;
Levi, Shai ;
Bronstein, Yotam ;
Morales, Miguel ;
Ziv, Tomer ;
Arbel, Yamit Shorer ;
Scarfo, Lydia ;
Joffe, Erel ;
Perry, Chava ;
Ghia, Paolo .
BLOOD, 2021, 137 (23) :3165-3173
[5]   Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study [J].
Monin, Leticia ;
Laing, Adam G. ;
Munoz-Ruiz, Miguel ;
McKenzie, Duncan R. ;
Del Barrio, Irene Del Molino ;
Alaguthurai, Thanussuyah ;
Domingo-Vila, Clara ;
Hayday, Thomas S. ;
Graham, Carl ;
Seow, Jeffrey ;
Abdul-Jawad, Sultan ;
Kamdar, Shraddha ;
Harvey-Jones, Elizabeth ;
Graham, Rosalind ;
Cooper, Jack ;
Khan, Muhammad ;
Vidler, Jennifer ;
Kakkassery, Helen ;
Sinha, Shubhankar ;
Davis, Richard ;
Dupont, Liane ;
Quijorna, Isaac Francos ;
O'Brien-Gore, Charlotte ;
Lee, Puay Ling ;
Eum, Josephine ;
Poole, Maria Conde ;
Joseph, Magdalene ;
Davies, Daniel ;
Wu, Yin ;
Swampillai, Angela ;
North, Bernard, V ;
Montes, Ana ;
Harries, Mark ;
Rigg, Anne ;
Spicer, James ;
Malim, Michael H. ;
Fields, Paul ;
Patten, Piers ;
Di Rosa, Francesca ;
Papa, Sophie ;
Tree, Timothy ;
Doores, Katie J. ;
Hayday, Adrian C. ;
Irshad, Sheeba .
LANCET ONCOLOGY, 2021, 22 (06) :765-778
[6]   Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma [J].
Perry, C. ;
Luttwak, E. ;
Balaban, R. ;
Shefer, G. ;
Morales, M. M. ;
Aharon, A. ;
Tabib, Y. ;
Cohen, Y. C. ;
Benyamini, N. ;
Beyar-Katz, O. ;
Neaman, M. ;
Vitkon, R. ;
Keren-Khadmy, N. ;
Levin, M. ;
Herishanu, Y. ;
Avivi, I .
BLOOD ADVANCES, 2021, 5 (16) :3053-3061